AgomAb director David Epstein buys $103,500 of shares after a steep fall
AgomAb Therapeutics director David Epstein bought 15,000 shares with personal money on November 5, for $103,500, and the filing became public on November 6.
The purchases
1 insider
Purchase on Nov 5, filed on Nov 6
1
Buyer
$103.5k
Bought
0
Sellers
Director
DE
David R Epstein
Buy · $103.5k · 15,000 shares
+60.0%
On the right, by how much each one increased the number of shares they own. Purchases declared to the SEC, the US stock market watchdog (Form 4), decided on the spot and not scheduled in advance.
AI analysis
Nov 6
With TrueWallet Pro
Why these purchases matter given where the stock stands, and what they do not say. Upgrade to Pro from the TrueWallet app.